blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3013355

EP3013355 - IL-2 FOR USE IN TREATING ALZHEIMER DISEASE AND RELATED DISORDERS [Right-click to bookmark this link]
Former [2016/18]BOOSTING TREG CELLS FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS
[2018/13]
StatusNo opposition filed within time limit
Status updated on  03.07.2020
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  05.07.2019
FormerGrant of patent is intended
Status updated on  13.02.2019
FormerExamination is in progress
Status updated on  09.11.2018
FormerGrant of patent is intended
Status updated on  22.03.2018
FormerExamination is in progress
Status updated on  14.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
ICM - Institut du Cerveau et de la Moelle Epinière
Hôpital Pitié Salpêtrière
47/83, Boulevard de l'Hôpital
75013 Paris / FR
For all designated states
APHP (Assistance Publique - Hôpitaux de Paris)
3 Avenue Victoria
75001 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75116 Paris / FR
For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101 rue de Tolbiac
75654 Paris Cedex 13 / FR
For all designated states
SORBONNE UNIVERSITE
21 rue de l'École de Médecine
75006 Paris / FR
[2019/32]
Former [2019/18]For all designated states
ICM - Institut du Cerveau et da la Moelle Epinière
Hôpital Pitié Salpêtrière
47/83, Boulevard de l'Hôpital
75013 Paris / FR
For all designated states
APHP (Assistance Publique - Hôpitaux de Paris)
3 Avenue Victoria
75001 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75116 Paris / FR
For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101 rue de Tolbiac
75654 Paris Cedex 13 / FR
For all designated states
SORBONNE UNIVERSITE
21 rue de l'École de Médecine
75006 Paris / FR
Former [2019/11]For all designated states
ICM - Institut du Cerveau et da la Moelle Epinière
Hôpital Pitié Salpêtrière
47/83, Boulevard de l'Hôpital
75013 Paris / FR
For all designated states
APHP (Assistance Publique - Hôpitaux de Paris)
3 Avenue Victoria
75001 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75116 Paris / FR
For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101 rue de Tolbiac
75654 Paris Cedex 13 / FR
For all designated states
Université Pierre et Marie Curie - Paris 6 (UPMC)
4 place Jussieu
75005 Paris / FR
Former [2016/18]For all designated states
ICM - Institut du Cerveau et da la Moelle Epinière
Hôpital Pitié Salpêtrière
47/83, Boulevard de l'Hôpital
75013 Paris / FR
For all designated states
APHP (Assistance Publique - Hôpitaux de Paris)
3 Avenue Victoria
75001 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (CNRS)
3 rue Michel-Ange
75016 Paris / FR
For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101 rue de Tolbiac
75654 Paris Cedex 13 / FR
For all designated states
Université Pierre et Marie Curie - Paris 6 (UPMC)
4 place Jussieu
75005 Paris / FR
Inventor(s)01 / DOROTHÉE, Guillaume
141 rue Gambetta
F-94120 Fontenay-sous-Bois / FR
02 / PIAGGIO, Eliane
77 rue de la Mare
F-75020 Paris / FR
03 / AIT AHMED, Dylla
14 rue du Pressoir
F-75020 Paris / FR
04 / AUCOUTURIER, Pierre
75 avenue du Colonel Fabien
F-93100 Montreuil / FR
 [2016/18]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2019/32]
Former [2016/18]Icosa
83 avenue Denfert-Rochereau
75014 Paris / FR
Application number, filing date14733140.920.06.2014
[2016/18]
WO2014EP63080
Priority number, dateEP2013017361725.06.2013         Original published format: EP 13173617
US201361838984P25.06.2013         Original published format: US 201361838984 P
[2016/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014206899
Date:31.12.2014
Language:EN
[2014/53]
Type: A1 Application with search report 
No.:EP3013355
Date:04.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 31.12.2014 takes the place of the publication of the European patent application.
[2016/18]
Type: B1 Patent specification 
No.:EP3013355
Date:07.08.2019
Language:EN
[2019/32]
Search report(s)International search report - published on:EP31.12.2014
ClassificationIPC:A61K38/20, A61P25/28
[2016/18]
CPC:
A61K38/2013 (EP,US); A61K38/20 (EP,US); A61K45/06 (US);
A61P25/28 (EP); A61K2039/545 (US); C07K14/55 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/18]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:IL-2 ZUR VERWENDUNG IN DER BEHANDLUNG VON ALZHEIMER-KRANKHEIT UND VERWANDTEN ERKRANKUNGEN[2018/09]
English:IL-2 FOR USE IN TREATING ALZHEIMER DISEASE AND RELATED DISORDERS[2018/13]
French:IL-2 POUR UTILISATION DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET DE TROUBLES ASSOCIES[2018/09]
Former [2016/18]VERSTÄRKUNG VON TREG-ZELLEN ZUR BEHANDLUNG VON MORBUS ALZHEIMER UND VERWANDTEN ERKRANKUNGEN
Former [2016/18]BOOSTING TREG CELLS FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS
Former [2016/18]STIMULATION DE CELLULES TREG POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET DE TROUBLES APPARENTÉS
Entry into regional phase25.01.2016National basic fee paid 
25.01.2016Designation fee(s) paid 
25.01.2016Examination fee paid 
Examination procedure22.01.2016Amendment by applicant (claims and/or description)
25.01.2016Examination requested  [2016/18]
11.10.2016Despatch of a communication from the examining division (Time limit: M04)
10.02.2017Reply to a communication from the examining division
27.06.2017Despatch of a communication from the examining division (Time limit: M06)
27.12.2017Reply to a communication from the examining division
21.03.2018Communication of intention to grant the patent
06.09.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
09.11.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.12.2018Despatch of a communication from the examining division (Time limit: M04)
05.12.2018Reply to a communication from the examining division
14.02.2019Communication of intention to grant the patent
13.06.2019Fee for grant paid
13.06.2019Fee for publishing/printing paid
13.06.2019Receipt of the translation of the claim(s)
Opposition(s)03.06.2020No opposition filed within time limit [2020/32]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
09.11.2018Request for further processing filed
09.11.2018Full payment received (date of receipt of payment)
Request granted
28.11.2018Decision despatched
Fees paidRenewal fee
30.06.2016Renewal fee patent year 03
30.06.2017Renewal fee patent year 04
18.06.2018Renewal fee patent year 05
27.06.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.06.2014
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
[2022/32]
Former [2022/27]HU20.06.2014
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2021/12]AL07.08.2019
AT07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/37]AL07.08.2019
AT07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/27]AL07.08.2019
AT07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/25]AL07.08.2019
AT07.08.2019
CZ07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SK07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/23]AL07.08.2019
AT07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/22]AL07.08.2019
EE07.08.2019
ES07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/17]AL07.08.2019
ES07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
TR07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/15]AL07.08.2019
ES07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/11]ES07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
BG07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/10]LT07.08.2019
NL07.08.2019
BG07.11.2019
PT09.12.2019
Former [2020/09]LT07.08.2019
NL07.08.2019
Former [2020/08]LT07.08.2019
Cited inInternational search[XY]US2005260767  (CLERICI MARIO [IT], et al) [X] 1,3,10-13 * abstract * * paragraphs [0033] , [0034] , [0037] , [0048] , [0049] * * claims 14,16,17,20 * [Y] 1-14;
 [XYI]WO2012123381  (ASSIST PUBL HOPITAUX DE PARIS [FR], et al) [X] 1-3,5-11,13,14 * abstract * * page 2, lines 19,20 * * page 3 * * page 4, lines 3,4 * * page 5, line 21 * * page 17, lines 15-17 * * page 25 - page 26 * * claims 1,29,30,36 * [Y] 1-14 [I] 4;
 [A]  - ROSENKRANZ ET AL, "Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration", JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (20070727), vol. 188, no. 1-2, doi:10.1016/J.JNEUROIM.2007.05.011, ISSN 0165-5728, pages 117 - 127, XP022206091 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jneuroim.2007.05.011
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.